Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Which is more tax-efficient for retirement: ETF or mutual fund? A clear comparison of tax features and practical implications.
28,114 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
SPHY has delivered monthly income since 2012, but 2026 tests whether its high-yield payout can withstand cyclical str...
Early indicators point to a modest 2027 social security cola, around 2.8%, but higher Medicare premiums could erode t...
In a volatile energy market, two durable picks stand out as no-brainer energy stocks right for many portfolios. Learn...
Buying a property that doesn’t cash flow right away can feel risky. This guide explains when negative cash flow can m...
A new policy debate threatens to tax the income universities earn from licensing taxpayer-funded research, potentiall...
A rare market move and a lofty valuation metric have many investors asking what happens next. This guide breaks down ...
Boyd Group stock since its IPO has posted a meaningful climb. This piece breaks down the factors behind the move, wha...
A notable stake in Patterson-UTI Energy raises questions about a possible oil-service rebound. This article dives int...
Father’s Day can sting when a parent is gone. This article uses dawson’s daughter charlotte says to explore how memor...
A Kentucky GOP primary produced a win for a Trump-backed challenger, marking a new chapter in Trump’s hold on the par...
A major fund trimmed Freshworks stock by hundreds of thousands of shares, triggering a 60% year-long drop in the stoc...